Print
Binghe Wang, Ph.D.
Professor of Chemistry, Georgia Research Alliance
Eminent Scholar in Drug Discovery
Georgia Cancer Coalition Distinguished Cancer Scientist
Atlanta, Georgia
Dr. Binghe Wang received his B.S. degree from Beijing Medical College (now Beijing University Health Sciences Center) and Ph.D. in medicinal chemistry from the University of Kansas. He completed postdoctoral training at both the University of Arizona and the University of Kansas, before embarking on his independent career at the University of Oklahoma College of Pharmacy in 1994. He moved to the Department of Chemistry, North Carolina State University in 1996. In July 2003, he moved to Georgia State University as Professor of Chemistry, Georgia Research Alliance Eminent Scholar in Drug Discovery, and Georgia Cancer Coalition Distinguished Cancer Scientist. In 2007, he received the Alumni Distinguished Professor Award by Georgia State University, which is one of the highest honors GSU bestows upon its faculty for academic achievements.
Dr. Binghe Wang received his B.S. degree from Beijing Medical College (now Beijing University Health Sciences Center) and Ph.D. in medicinal chemistry from the University of Kansas. He completed postdoctoral training at both the University of Arizona and the University of Kansas, before embarking on his independent career at the University of Oklahoma College of Pharmacy in 1994. He moved to the Department of Chemistry, North Carolina State University in 1996. In July 2003, he moved to Georgia State University as Professor of Chemistry, Georgia Research Alliance Eminent Scholar in Drug Discovery, and Georgia Cancer Coalition Distinguished Cancer Scientist. In 2007, he received the Alumni Distinguished Professor Award by Georgia State University, which is one of the highest honors GSU bestows upon its faculty for academic achievements.
About the lecture
"Going after the ‘Sweet Spot’ in Selecting Aptamers for Glycoproteins"
It is well known that protein post/co-translational modifications are very important in determining its functions. However, there is a general lack of tools for the rapid and specific assessment of protein modification status. This is especially true with glycosylation.
Many proteins, such as prostate specific antigen (PSA), show different glycosylations patterns depending on whether they are of cancer origin. Therefore, glycosylation states are often excellent biomarkers for cancer and other pathological changes. Tools that allow for the rapid identification of glycosylation states of a given protein are very important for biomedical research and the development of new diagnostics.
Quoted from the 2007-2008 Loyd E. Harris Lecture Series Announcement Brochure